Xiaowen Liu, Ph.D, Senior Scientist, joined Osel in 2001, and has been working on developing and optimizing Osel's MucoCept technology. She has contributed significantly to overcome technical issues associated with cloning and aberrant processing of anti-viral proteins in Lactobacillus jensenii and other relevant Lactobacillus species. Dr. Liu received her Ph.D from SUNY-Binghamton. She was trained as a postdoctoral fellow at Cornell University, where she developed a mouse model to elucidate mechanisms of B-vitamin folate-related pathologies, and investigated the translational control of gene expression related to folate-mediated one-carbon metabolism.
Yang Liu, Ph.D has been serving as the Microbiology Leader since September 2005. Dr. Liu leads the Microbiology Core in support of NIH funded IPCP program and Vaginal Lactobacillus Genome Sequencing and Analysis Program. Before joining Osel, Dr. Liu was a postdoctoral researcher studying genetics and functional genomics of a human pathogen Mycobacterium tuberculosis at Stanford University School of Medicine. Dr. Liu received his Ph.D. in Genetics from the University of Missouri, Columbia.
Rosa R. Yu, Ph.D, Senior Scientist, joined Osel in 2005 and her work primarily focuses on understanding the biology of vaginal microflora and the development of a non-human primate model that is suitable for evaluating colonization of our Lactobacillus-based topical microbicide candidates. Dr Yu received her Ph.D. in Microbiology and Immunology from the University of Michigan - Ann Arbor, on the regulation of virulence gene expression in the human pathogen Vibrio cholerae. She was a postdoctoral fellow in the Department of Biochemistry at Stanford University School of Medicine, where she investigated the mechanism of adventurous-motility in Myxococcus xanthus.